News & Updates

Do GLP1 receptor agonists increase thyroid cancer risk?

20 Apr 2024 by

Use of glucagon-like peptide 1 (GLP1) receptor agonists does not contribute to an elevated risk of thyroid cancer, as shown in a Scandinavian cohort study with a mean follow-up of nearly 4 years.

Do GLP1 receptor agonists increase thyroid cancer risk?

20 Apr 2024

Keeping blood sugar under control reduces CRC risk in people with diabetes

20 Apr 2024

For individuals with diabetes mellitus (DM), optimal glycaemic control may protect against the risk of developing colonic adenoma and colorectal cancer (CRC), as reported in a population-based cohort study.

Keeping blood sugar under control reduces CRC risk in people with diabetes

20 Apr 2024

Is it safe to use GLP1 agonists, SGLT2 inhibitors in patients on multiple insulin injections?

18 Apr 2024

Patients using multiple insulin injections demonstrate no significant difference in changes to A1c, insulin requirements, or weight after a year of treatment with a sodium glucose transporter 2 (SGLT2) inhibitor or glucagon-like peptide 1 (GLP1) receptor agonist, as shown in a study.

Is it safe to use GLP1 agonists, SGLT2 inhibitors in patients on multiple insulin injections?

18 Apr 2024

Vitamin D insufficiency in early pregnancy highly prevalent in SG

17 Apr 2024 by

A local study has raised concerns about a high rate of hypovitaminosis D in early pregnancy in Singapore.

Vitamin D insufficiency in early pregnancy highly prevalent in SG

17 Apr 2024

GLP-1RAs may improve long-term liver outcomes in T2D patients with MASLD

17 Apr 2024

For patients with type 2 diabetes (T2D) and metabolic dysfunction-associated steatotic liver disease (MASLD) cirrhosis, treatment with glucagon-like peptide-1 receptor agonists helps reduce the risk of hepatic decompensation, portal hypertension, hepatocellular carcinoma, and liver transplantation, according to a study.

GLP-1RAs may improve long-term liver outcomes in T2D patients with MASLD

17 Apr 2024

Inverse relationship between obesity, aortic pressure augmentation inhibited in women

16 Apr 2024

Overweight or obesity is inversely associated with aortic pressure augmentation from peripheral wave reflection, but this association is attenuated in women, reveals a study.

Inverse relationship between obesity, aortic pressure augmentation inhibited in women

16 Apr 2024

20-year study challenges link between gestational diabetes and ADHD

16 Apr 2024 by

Gestational diabetes mellitus (GDM) is not associated with attention-deficit/hyperactivity disorder (ADHD) in offspring, a 20-year multinational study has shown.

20-year study challenges link between gestational diabetes and ADHD

16 Apr 2024

SGLT2 inhibitors suitable for patients with T2D and NAFLD

14 Apr 2024

Clinicians may favour prescribing sodium-glucose cotransporter 2 (SGLT2) inhibitors to patients with both type 2 diabetes (T2D) and nonalcoholic fatty liver disease (NAFLD), with the drugs having potential benefits in terms of NAFLD regression and reduced incidences of adverse liver-related outcomes, according to a study.

SGLT2 inhibitors suitable for patients with T2D and NAFLD

14 Apr 2024

APOC3 inhibition shows therapeutic potential in severe hypertriglyceridemia

10 Apr 2024 by

Treatment with plozasiran, an experimental small interfering–RNA drug that targets apolipoprotein C3 (APOC3) gene, helps regulate triglyceride levels, bringing them below the critical threshold associated with acute pancreatitis for most patients with severe hypertriglyceridemia, according to the phase IIb SHASTA-2* study.

APOC3 inhibition shows therapeutic potential in severe hypertriglyceridemia

10 Apr 2024

Healthy diet fails to offset diabetes risk for short sleepers

09 Apr 2024

A recent study suggests that adopting a healthy diet does protect against the risk of developing type 2 diabetes (T2D) among people with habitual short sleep duration, according to a study.

Healthy diet fails to offset diabetes risk for short sleepers

09 Apr 2024

News & Updates

Filter by Specialty:

Specialty:

Do GLP1 receptor agonists increase thyroid cancer risk?

Do GLP1 receptor agonists increase thyroid cancer risk?

Keeping blood sugar under control reduces CRC risk in people with diabetes

Keeping blood sugar under control reduces CRC risk in people with diabetes

Is it safe to use GLP1 agonists, SGLT2 inhibitors in patients on multiple insulin injections?

Is it safe to use GLP1 agonists, SGLT2 inhibitors in patients on multiple insulin injections?

Vitamin D insufficiency in early pregnancy highly prevalent in SG

Vitamin D insufficiency in early pregnancy highly prevalent in SG

GLP-1RAs may improve long-term liver outcomes in T2D patients with MASLD

GLP-1RAs may improve long-term liver outcomes in T2D patients with MASLD

Inverse relationship between obesity, aortic pressure augmentation inhibited in women

Inverse relationship between obesity, aortic pressure augmentation inhibited in women

20-year study challenges link between gestational diabetes and ADHD

20-year study challenges link between gestational diabetes and ADHD

SGLT2 inhibitors suitable for patients with T2D and NAFLD

SGLT2 inhibitors suitable for patients with T2D and NAFLD

APOC3 inhibition shows therapeutic potential in severe hypertriglyceridemia

APOC3 inhibition shows therapeutic potential in severe hypertriglyceridemia

Healthy diet fails to offset diabetes risk for short sleepers

Healthy diet fails to offset diabetes risk for short sleepers